Author

L. Mendoza-Viveros

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Physiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Approach:experimental assay· 1 Research Focus:metabolism & bioenergetics· 1 Organism:mouse· 1

Frequent Co-Authors

E. Carreno-Vazquez· 1 shared F. Becerril-Perez· 1 shared I. Pacheco-Bernal· 1 shared L. Aguilar-Arnal· 1 shared M. Bustamante-Zepeda· 1 shared M. Gonzalez-Suarez· 1 shared P. Mass-Sanchez· 1 shared Q. Escalante-Covarrubias· 1 shared

Activity by Year

2022-2022 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPhysiology

E. Carreno-Vazquez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

PhysiologybioRxivPreprintAug 12, 2022

Time-of-day defines the efficacy of NAD+ to treat diet-induced metabolic disease by adjusting oscillations of the hepatic circadian clock

Q. Escalante-Covarrubias, L. Mendoza-Viveros, M. Gonzalez-Suarez…·L. Aguilar-Arnal

This study shows that the time of day affects the effectiveness of NAD+ therapy for diet-induced metabolic disease in mice by influencing hepatic circadian rhythms.

DOI 10.1101/2022.08.12.503453

mousebulk RNA-seq

𝕏 PostBluesky